Dyax Corporation SWOT

  • October 2011
  • -
  • MarketLine

examines the firm ’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Dyax, a development stage biopharmaceutical firm , is focused on developing and commercializing products for inflammatory and oncology indications. The firm , through its proprietary drug discovery technology, known as phage display, identifies antibody, small protein and peptide compounds for clinical development. Dyax’s Kalbitor (ecallantide) is approved for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. The industry player is headquartered in Cambridge, Massachusetts and employed 121 people as of February 01, 2010. The industry player recorded sales of USD 21.6 million during the financial year (FY) ended December 2009, a decrease of 50.2% over FY2008. The operating loss of the industry player was USD 54.1 million in FY2009, as compared to an operating loss of USD 52.3 million in FY2008. The net loss was USD 62.4 million in FY2009, as compared to a net loss of USD 66.5 million in FY2008.

What's Included In This Report?

- Provides all the crucial information on Dyax Corporation required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Dyax Corporation in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Dyax Corporation
-Data is supplemented with details on Dyax Corporation history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Dyax Corporation

Why Should You Buy This Report?

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date industry player information available

Table Of Contents

Table of Contents:

SWOT COMPANY PROFILE: Dyax Corporation
Facts and Figures : Dyax Corporation
Corporate Description : Dyax Corporation
Business Overview : Dyax Corporation
Company History: Dyax Corporation
Top Executives : Dyax Corporation
Resumees : Dyax Corporation
Business Lines (products and services) : Dyax Corporation
Products and Services Analysis: Dyax Corporation
Strategic analysis (SWOT) : Dyax Corporation
*Strengths: Dyax Corporation
*Weaknesses: Dyax Corporation
*Opportunities: Dyax Corporation
*Threats: Dyax Corporation
Company View: Dyax Corporation
Competitive Landscape : Dyax Corporation
Subsidiary : Dyax Corporation
*Head Office: Dyax Corporation
*Other Locations and Subsidiaries: Dyax Corporation

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Bristol-Myers Squibb Company - Product Pipeline Review - 2014

Bristol-Myers Squibb Company - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Bristol-Myers Squibb Company - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Bristol-Myers Squibb Company - Product Pipeline Review - 2014', provides an overview of the Bristol-Myers ...

Pfenex Inc. - Product Pipeline Review - 2014

Pfenex Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Pfenex Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Pfenex Inc. - Product Pipeline Review - 2014', provides an overview of the Pfenex Inc.'s pharmaceutical research and development ...

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014', provides an overview of the Genervon ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.